NasdaqCM - Nasdaq Real Time Price USD
Salarius Pharmaceuticals, Inc. (SLRX)
0.7190
+0.0600
+(9.10%)
At close: April 23 at 4:00:01 PM EDT
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
-4,525.3370
-4,525.3370
-12,846.1370
-17,595.3210
-10,200.1970
Investing Cash Flow
--
--
--
-1,500
--
Financing Cash Flow
1,059.9550
1,059.9550
6,639.6120
1,987.3760
28,295.9630
End Cash Position
2,434.5280
2,434.5280
5,899.9100
12,106.4350
29,214.3800
Interest Paid Supplemental Data
10.6430
10.6430
14.7540
--
1.4680
Capital Expenditure
--
--
--
-1,500
--
Issuance of Capital Stock
1,526.4600
1,526.4600
6,920.5290
1,987.3760
27,287.6380
Repayment of Debt
-466.5050
-466.5050
-280.9170
--
-477.0280
Free Cash Flow
-4,525.3370
-4,525.3370
-12,846.1370
-19,095.3210
-10,200.1970
12/31/2021 - 1/29/2015
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
PHIO Phio Pharmaceuticals Corp.
2.0400
-18.73%
TSBX Turnstone Biologics Corp.
0.3164
+2.23%
HOTH Hoth Therapeutics, Inc.
0.8321
+4.01%
EYEN Eyenovia, Inc.
1.0901
+0.01%
LIXT Lixte Biotechnology Holdings, Inc.
1.3000
+15.04%
AZTR Azitra, Inc.
0.2950
+3.87%
ACTU Actuate Therapeutics, Inc. Common stock
9.00
+5.63%
JUNS Jupiter Neurosciences, Inc.
0.6544
+2.33%
NBY NovaBay Pharmaceuticals, Inc.
0.5772
-1.27%
QUIA.ST Quia Pharma AB (publ)
0.0109
-3.54%